MRI Relaxometry for Quantitative Analysis of USPIO Uptake in Cerebral Small Vessel Disease

Quantitative susceptibility mapping (QSM) and R 2 * in the human brain at 3 T

(2018) Xiang Feng et al.   Zeitschrift fur Medizinische Physik

Ferumoxytol-enhanced magnetic resonance imaging assessing inflammation after myocardial infarction

(2017) Colin G Stirrat et al.   HEART

Cerebrovascular reactivity measurement in cerebral small vessel disease: Rationale and reproducibility of a protocol for MRI acquisition and image processing

(2017) Michael J Thrippleton et al.   International Journal of Stroke

Metric to quantify white matter damage on brain magnetic resonance images

(2017) Maria Del C. Valdés Hernández et al.   NEURORADIOLOGY

Integrity of normal-appearing white matter: Influence of age, visible lesion burden and hypertension in patients with small-vessel disease

(2016) Susana Muñoz Maniega et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

A USPIO doped gel phantom for R2* relaxometry

(2016) Gregory C. Brown et al.   MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE

Tracer kinetic modelling for DCE-MRI quantification of subtle blood–brain barrier permeability

(2016) Anna K. Heye et al.   NEUROIMAGE

Rationale, design and methodology of the image analysis protocol for studies of patients with cerebral small vessel disease and mild stroke

(2015) Maria del C. Valdés Hernández et al.   Brain and Behavior

On the accuracy of T1mapping: Searching for common ground

(2014) Nikola Stikov et al.   MAGNETIC RESONANCE IN MEDICINE

Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden

(2014) J. Staals et al.   NEUROLOGY

Circulating Inflammatory Markers Are Associated With Magnetic Resonance Imaging-Visible Perivascular Spaces But Not Directly With White Matter Hyperintensities

(2014) Benjamin S. Aribisala et al.   STROKE

High-Resolution Steady-State Cerebral Blood Volume Maps in Patients with Central Nervous System Neoplasms Using Ferumoxytol, a Superparamagnetic Iron Oxide Nanoparticle

(2013) Csanad G Varallyay et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Microbleeds in cerebral small vessel disease – Authors' reply

(2013) Joanna Wardlaw et al.   LANCET NEUROLOGY

ΔR2*gadolinium-diethylenetriaminepentacetic acid relaxivity in venous blood

(2012) Vishal Patil et al.   MAGNETIC RESONANCE IN MEDICINE

In vivo venous blood T1 measurement using inversion recovery true-FISP in children and adults

(2010) Wen-Chau Wu et al.   MAGNETIC RESONANCE IN MEDICINE

White matter hyperintensity volume is increased in small vessel stroke subtypes

(2010) N. S. Rost et al.   NEUROLOGY

Lacunar stroke is associated with diffuse blood-brain barrier dysfunction

(2009) Joanna M. Wardlaw et al.   ANNALS OF NEUROLOGY

Superparamagnetic Iron Oxide Nanoparticles: Diagnostic Magnetic Resonance Imaging and Potential Therapeutic Applications in Neurooncology and Central Nervous System Inflammatory Pathologies, a Review

(2009) Jason S Weinstein et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Bolus-tracking MRI with a simultaneousT1- andT2*-measurement

(2009) S. Sourbron et al.   MAGNETIC RESONANCE IN MEDICINE

MP2RAGE, a self bias-field corrected sequence for improved segmentation and T1-mapping at high field

(2009) José P. Marques et al.   NEUROIMAGE

A theoretical framework to model DSC-MRI data acquired in the presence of contrast agent extravasation

(2009) C C Quarles et al.   PHYSICS IN MEDICINE AND BIOLOGY

Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?

(2008) Edward A. Neuwelt et al.   KIDNEY INTERNATIONAL

Susceptibility contrast in high field MRI of human brain as a function of tissue iron content

(2008) B YAO et al.   NEUROIMAGE